The CEO Corner is intended to provide additional and in-depth perspective to press releases, corporate developments and development pipeline progress.
January 9, 2026
November 25, 2025
AN INNOVATIVE TARGETED ONCOLOGY COMPANY BUILT ON NEXT GENERATION ANTIBODY-DRUG CONJUGATES (ADC) AND A NOVEL DISCOVERY ENGINE